ReportGem ReportGem

U.S. COMPANY FILING

Merck & Co., Inc. — Form 8-K filed 2026-04-30

Filed: 2026-04-30Company: Merck & Co., Inc.Ticker: MRKExchange: NYSEForm: 8-KReport period: 2026-04-30SEC accession: 0001104659-26-052081Event: earningsMateriality: 0

Filing text preview

Merck filed an 8-K on April 30, 2026, furnishing its Q1 2026 earnings press release and supplemental information. The filing includes registration details for common stock and notes, and states the information is furnished, not filed, under the Exchange Act.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2026-04-30Merck and Moderna's Melanoma Vaccine Trial Positive, Vaccine Themed ETFs Surge2026-08-20S&P 500 and Nasdaq Edge Higher, Led by Moderna and Merck2026-08-2010-Q2026-08-07 · 10-QFORM 8-K2026-08-04 · 8-K1Q26 FORM 10-Q2026-05-04 · 10-Q10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 20252026-02-24 · 10-KFORM 8-K2026-02-03 · 8-K